186 related articles for article (PubMed ID: 29265783)
1. TSH-receptor autoantibodies: pathophysiology, assay methods, and clinical applications.
Ehlers M; Allelein S; Schott M
Minerva Endocrinol; 2018 Sep; 43(3):323-332. PubMed ID: 29265783
[TBL] [Abstract][Full Text] [Related]
2. Functional diagnostics for thyrotropin hormone receptor autoantibodies: bioassays prevail over binding assays.
Lytton SD; Schluter A; Banga PJ
Front Biosci (Landmark Ed); 2018 Jun; 23(11):2028-2043. PubMed ID: 29772543
[TBL] [Abstract][Full Text] [Related]
3. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
4. Stimulating TSH receptor autoantibodies immunoassay: analytical evaluation and clinical performance in Graves' disease.
Autilio C; Morelli R; Locantore P; Pontecorvi A; Zuppi C; Carrozza C
Ann Clin Biochem; 2018 Jan; 55(1):172-177. PubMed ID: 28388869
[TBL] [Abstract][Full Text] [Related]
5. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
Nicolì F; Lanzolla G; Mantuano M; Ionni I; Mazzi B; Leo M; Sframeli A; Posarelli C; Maglionico MN; Figus M; Nardi M; Marcocci C; Marinò M
J Endocrinol Invest; 2021 Mar; 44(3):581-585. PubMed ID: 32648002
[TBL] [Abstract][Full Text] [Related]
6. Thyroid stimulating receptor autoantibodies.
Gao Y; Qiu L; Yu S; Cheng X
Clin Chim Acta; 2024 Jun; 559():119700. PubMed ID: 38697458
[TBL] [Abstract][Full Text] [Related]
7. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
[TBL] [Abstract][Full Text] [Related]
8. Practical applications of studies on the TSH receptor and TSH receptor autoantibodies.
Furmaniak J; Sanders J; Sanders P; Miller-Gallacher J; Ryder MM; Rees Smith B
Endocrine; 2020 May; 68(2):261-264. PubMed ID: 32472423
[TBL] [Abstract][Full Text] [Related]
9. Techniques to quantify TSH receptor antibodies.
Ajjan RA; Weetman AP
Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):461-8. PubMed ID: 18574503
[TBL] [Abstract][Full Text] [Related]
10. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter.
Wallaschofski H; Orda C; Georgi P; Miehle K; Paschke R
Horm Metab Res; 2001 Aug; 33(8):504-7. PubMed ID: 11544566
[TBL] [Abstract][Full Text] [Related]
11. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
Morshed SA; Ando T; Latif R; Davies TF
Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
[TBL] [Abstract][Full Text] [Related]
12. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
13. Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment.
Wallaschofski H; Miehle K; Mayer A; Tuschy U; Hentschel B; Paschke R
Horm Metab Res; 2002 Jul; 34(7):383-8. PubMed ID: 12189586
[TBL] [Abstract][Full Text] [Related]
14. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
15. Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves disease and for the follow-up of Graves ophthalmopathy.
Massart C; Sapin R; Gibassier J; Agin A; d'Herbomez M
Clin Chem; 2009 Jan; 55(1):183-6. PubMed ID: 19028818
[TBL] [Abstract][Full Text] [Related]
16. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication.
Smith J; Brown RS
Thyroid; 2007 Nov; 17(11):1103-7. PubMed ID: 17822376
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to the thyrotropin receptor.
Rees Smith B; McLachlan SM; Furmaniak J
Endocr Rev; 1988 Feb; 9(1):106-21. PubMed ID: 3286231
[TBL] [Abstract][Full Text] [Related]
18. [The latest progress in the pathogenesis and diagnosis of Graves' disease].
Kimura T; Okamoto Y
Nihon Rinsho; 2012 Nov; 70(11):1908-12. PubMed ID: 23214060
[TBL] [Abstract][Full Text] [Related]
19. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
